Evidence map›Paper›PMID 37242999›Full record

ArticleVaccines2023

A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities.

Laila N Khorasani, Asal Bastani, Tammy Shen, Gurlovellen Kaur, Nilpa D Shah, Lucia Juarez, Michelle Heyman, Julie Grassian, An-Chuen Cho, Emily Hotez

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Laila N KhorasaniDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Asal BastaniDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0002-2433-1504
Tammy ShenDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0006-2969-9814
Gurlovellen KaurDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0002-4628-649X
Nilpa D ShahDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0001-8199-7145
Lucia JuarezDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Michelle HeymanGraduate School of Education, University of California, Riverside, CA 92521, USA.
Julie GrassianDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0001-4041-5417
An-Chuen ChoDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Emily HotezDavid Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
University of California, Los Angeles · USUniversity of California, Riverside · US

Funding

Association of University Centers on Disabilities CDC-RFA-DD21-2105
6 · The paper itself

Abstract

Vaccine hesitancy is a major barrier to vaccination, hindering the success of vaccine efforts and thereby increasing public health risk to viral diseases, including COVID-19. Neurodivergent (ND) individuals, including individuals with an intellectual and/or developmental disability, have demonstrated a heightened risk of hospitalization and death due to COVID-19, highlighting the need for further research specifically on ND communities. We conducted a qualitative analysis using in-depth interviews with medical professionals, non-medical health professionals and communicators, and ND individuals or their caregivers. Using a thematic coding analysis methodology, trained coders identified major themes according to 24 distinct codes spanning across the categories of (1) barriers to vaccination; (2) facilitators to vaccination; and (3) suggestions for improving vaccine confidence. Qualitative findings identify misinformation, perception of vaccine risk, sensory sensitivities, and structural hardship as the most significant barriers to COVID-19 vaccination. We highlight the importance of accommodations to vaccination for the ND community alongside coordinated efforts by healthcare leaders to direct their communities to accurate sources of medical information. This work will inform the direction of future research on vaccine hesitancy, and the development of programs specific to the ND community's access to vaccines.

Indexed as

COVID-19intellectual and developmental disabilityneurodivergentthematic codingvaccine hesitancy

Identifiers

PMID37242999
PMCPMC10221563
OpenAlexW4366986902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.